BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31347168)

  • 21. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.
    Pan MS; Wang H; Ansari KH; Li XP; Sun W; Fan YZ
    J Exp Clin Cancer Res; 2020 Nov; 39(1):234. PubMed ID: 33153467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway.
    Shen H; He M; Lin R; Zhan M; Xu S; Huang X; Xu C; Chen W; Yao Y; Mohan M; Wang J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):247. PubMed ID: 31182136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-20a triggers metastasis of gallbladder carcinoma.
    Chang Y; Liu C; Yang J; Liu G; Feng F; Tang J; Hu L; Li L; Jiang F; Chen C; Wang R; Yang Y; Jiang X; Wu M; Chen L; Wang H
    J Hepatol; 2013 Sep; 59(3):518-27. PubMed ID: 23665284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of PEAK1 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer through modulating ERK1/2 and JAK2 signaling.
    Ding C; Tang W; Fan X; Wang X; Wu H; Xu H; Xu W; Gao W; Wu G
    Cell Death Dis; 2018 Jul; 9(8):802. PubMed ID: 30038287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.
    Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB
    Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway.
    Wang Y; Jing Y; Ding L; Zhang X; Song Y; Chen S; Zhao X; Huang X; Pu Y; Wang Z; Ni Y; Hu Q
    J Exp Clin Cancer Res; 2019 Jun; 38(1):274. PubMed ID: 31234944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hedgehog signaling pathway is a potential therapeutic target for gallbladder cancer.
    Matsushita S; Onishi H; Nakano K; Nagamatsu I; Imaizumi A; Hattori M; Oda Y; Tanaka M; Katano M
    Cancer Sci; 2014 Mar; 105(3):272-80. PubMed ID: 24438533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-143-5p Deficiency Triggers EMT and Metastasis by Targeting HIF-1α in Gallbladder Cancer.
    He M; Zhan M; Chen W; Xu S; Long M; Shen H; Shi Y; Liu Q; Mohan M; Wang J
    Cell Physiol Biochem; 2017; 42(5):2078-2092. PubMed ID: 28803245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of FXR modulates SOCS3/Jak2/STAT3 signaling axis in a NASH-dependent hepatocellular carcinoma animal model.
    Attia YM; Tawfiq RA; Gibriel AA; Ali AA; Kassem DH; Hammam OA; Elmazar MM
    Biochem Pharmacol; 2021 Apr; 186():114497. PubMed ID: 33675775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MEX3C-Mediated Decay of SOCS3 mRNA Promotes JAK2/STAT3 Signaling to Facilitate Metastasis in Hepatocellular Carcinoma.
    Xiao Y; Li Y; Shi D; Wang X; Dai S; Yang M; Kong L; Chen B; Huang X; Lin C; Liao W; Xu B; Chen X; Wang L; Chen X; Ouyang Y; Liu G; Li H; Song L
    Cancer Res; 2022 Nov; 82(22):4191-4205. PubMed ID: 36112698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor suppressor LKB1 inhibits the progression of gallbladder carcinoma and predicts the prognosis of patients with this malignancy.
    Hu MT; Wang JH; Yu Y; Liu C; Li B; Cheng QB; Jiang XQ
    Int J Oncol; 2018 Sep; 53(3):1215-1226. PubMed ID: 30015925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen-related receptor-α promotes gallbladder cancer development by enhancing the transcription of Nectin-4.
    Wang L; Yang M; Guo X; Yang Z; Liu S; Ji Y; Jin H
    Cancer Sci; 2020 May; 111(5):1514-1527. PubMed ID: 32030850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2.
    Shen H; Zhan M; Zhang Y; Huang S; Xu S; Huang X; He M; Yao Y; Man M; Wang J
    Cell Death Dis; 2018 Jan; 9(2):71. PubMed ID: 29358655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
    Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J
    Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FOXA2 suppresses gallbladder carcinoma cell migration, invasion, and epithelial-mesenchymal transition by targeting SERPINB5.
    Hong L; Chen M; Huang M; Chen W; Abudukeremu X; She F; Chen Y
    Environ Toxicol; 2024 Feb; 39(2):708-722. PubMed ID: 37665156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma.
    Bao RF; Shu YJ; Hu YP; Wang XA; Zhang F; Liang HB; Ye YY; Li HF; Xiang SS; Weng H; Cao Y; Wu XS; Li ML; Wu WG; Zhang YJ; Jiang L; Dong Q; Liu YB
    Oncotarget; 2016 Apr; 7(16):22339-54. PubMed ID: 26968949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-203 regulates JAK-STAT pathway in affecting pancreatic cancer cells proliferation and apoptosis by targeting SOCS3.
    Lin XM; Chen H; Zhan XL
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6906-6913. PubMed ID: 31486490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Kindlin-2 promotes gallbladder cancer metastasis and invasion by inducing epithelial-mesenchymal transition].
    Lu X; Zhou C; Li RF; Ye JW; Zhai WL
    Zhonghua Wai Ke Za Zhi; 2018 Aug; 56(8):617-622. PubMed ID: 30107706
    [No Abstract]   [Full Text] [Related]  

  • 39. Artificial Downregulation of Ribosomal Protein L34 Restricts the Proliferation and Metastasis of Colorectal Cancer by Suppressing the
    Liang YC; Li R; Bao SR; Li ZL; Yin HZ; Dai CL
    Hum Gene Ther; 2023 Aug; 34(15-16):719-731. PubMed ID: 37427415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2-Phenylnaphthyridin-4-one Derivative LYF-11 Inhibits Interleukin-6-mediated Epithelial-to-Mesenchymal Transition
    Liu LC; Wu YC; Kuo SC; Ho CT; Way TD; Chen ST
    Anticancer Res; 2018 May; 38(5):2849-2859. PubMed ID: 29715108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.